Market Research Blog – Page 13287 – New Product Development

Container Liner Market to Witness a Healthy Growth by 2031

Container liner sales will consistently increase driven by application across diverse sectors. In a study Future Market Insights (FMI) presents a positive growth forecast for container liner market at 4.7% CAGR between 2021 and 2031.

After a period of tepid sales amid restrictions imposed in response to COVID-19 outbreak, growth will gradually recover. Expansion of packaging and food industries will present lucrative prospects for growth over the coming years.

Get Sample of the report : https://www.futuremarketinsights.com/reports/sample/rep-gb-2035

Container liner as a bulk packaging solution has gained immense popularity across the world. It is increasingly used for transporting bulk cargo safely from the one part of the world to another. These re-usable bulk container liners are used in shipping loose bulk cargo, which is yet to be filled inside the container to avoid tampering while transit.

The availability of different types of container liners such as end fill to cater to specific industry requirements will emerge as chief growth driver. As per the report end fill and wide access container liners will remain highly sought-after.

The availability of container liners has addressed the demand for protective and safe packaging solution in agricultural, chemical and pharmaceutical industries.

In the last few years, manufacturers have been focusing on the use of recyclable materials such as Polypropylene (PP), Polyvinyl Chloride (PVC), and metallized films. This is intended to ensure that adverse effects on the environment are curbed.

Such steps taken towards introducing sustainable packaging solutions will bode well for the market.

Key Takeaways from Container Liner Market

By material type, polypropylene material holds the dominant share of nearly 40% in the market.
The U.S. has emerged as a key market, accounting for nearly 87.8% of the North America container liner market in 2021.
After two consecutive years of marginal sales in 2020 and 2031, the U.K. market will exhibit 5.6% y-o-y growth by the next decade.
Rising in demand in the pharmaceutical sector will support growth in Germany and France.
Japan will emerge as an attractive market, driven by increasing application in the building and construction sector.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-2035

“Manufacturers are focusing on expanding their footprint globally. As a result there is high focus on strategic collaborations. Besides this, increasing emphasis on launching sustainable packaging solutions will drive growth in the market in the coming years.” says FMI analyst.

Demand for Lightweight Protective Packaging Solution for Bulk Cargo

A new packaging trend of lightweight packaging materials and products is witnessed in the industrial packaging and shipping industry. All requirements of these latest trends are met by container liners used for packaging and transport of dry, liquid and granule form of bulk cargo.

The easy handling of bulk packaging solutions such as container liner, which are easy to store and flexible since it can be folded and can be packed in small sized packs will aid its application. The easy to carry packaging and less space consuming attributes of container liner make them easy to be shipped from manufacturers to end users in a cost effective way.

Purchase the Report : https://www.futuremarketinsights.com/checkout/2035

Container Liner Market Landscape

Berry Global, Inc. and Grief, Inc., are the top players operating in the Container Liner market. Furthermore, LC Packaging International B.V., and Display Pack, Inc., are some of the leading players in the container liner market. Key players contribute almost 30-35% of the global market.

Barricade Tape Market : Technological Growth Map over Time

Global sales of barricade tapes are anticipated to increase by 1.6x between 2021 and 2031. Rising awareness regarding workplace safety to avoid any type of industrial accidents and prevent common people from entering restricted areas will propel the sales of barricade tapes across the globe.

Rising concerns regarding the safety of all types of employees at the construction sites, manufacturing facilities, mines and various other hazardous places are attracting humanitarian organizations.

Get Sample of the report : https://www.futuremarketinsights.com/reports/sample/rep-gb-2726

All those social and employee welfare organizations are mandating the use of barricade tape in companies, organizations and medium-sized workplaces where no standard safety protocols are being followed.

In addition to that, as a part of safety measures at places where the harmful and flammable goods are stored, those places require proper safety marking and labelling by barricade or security tapes.

Different coloured barricading tapes are manufactured by key players for indication of different types of dangers or hazards. Also, different types of printed tapes are used to alert people to various types of hazards.

For instance- red/white coloured tape for fire prevention & protective equipment, yellow/black coloured tape for caution, and red coloured tape for serious hazards and dangers.

Availability of a large number of colours in barricade tapes containing different texts for various threats is expected to fuel the demand for barricade tapes. End-users are focusing on providing end-user industries with the best-suited barricade tapes, printed with colours and text, indicating the potential hazards in their respective industries.

Key Takeaways from Barricade Tapes Market

Barricade tapes with a thickness ranging from 6 to 8mm is expected to record growth at 5% CAGR between 2021 and 2031. Barricade tapes with medium thickness offer cost-effective, durable and lightweight soft barricading solutions for end-use industries across the globe.
Expansion of building & construction industry across the U.S. will offer a total incremental opportunity of US$ 140 Mn over the next decade.
Easy availability, flexibility and hassle-free production process makes plastic as most preferred material by barricade tapes manufacturers across the regions. Plastic barricade tape is expected to account for 60% share in 2021.
Sales of barricade tapes used in industrial end users are anticipated to exhibit growth at 5% CAGR between 2021 and 2031, on the back of favourable stringent regulation for safety of employees and labor.
Germany is expected to be the largest market for barricade tapes in Europe accounting for almost 20% market share in 2021.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-2726

“Upgradation of workplace safety laws, along with the expansion of end-use industries such as automotive, construction, mining, and manufacturing will result in increased demand for barricade tapes across the globe. Moreover, producers of barricade tapes are developing sustainable tapes to woo environmentally conscious consumers across the globe,” says FMI analyst.

Increasing Popularity of Custom-built Barricade Tapes Showcases Intrinsic Growth Potential

In the modern-day, customized products and services are witnessing exponential growth, as people are more attracted towards a product or solution specifically designed to fulfil their needs. Customized products are more in demand as these products are tailor-made as a solution to existing problems faced by end-user industries.

Major manufacturers operating in the global barricade tapes market are eyeing various differentiation strategies to gain competitive edge and maintain dominance in the market. To offer unique versions of barricade tapes, these companies are offering a variety of customized options to end-user industries, in which clients choose the design, material, color and text written on the barricade tapes as per their needs.

Custom-built barricade tapes are expected to create a huge uproar in demand for barricade tapes across all regions and offering lucrative opportunities to the market players.

Purchase the Report : https://www.futuremarketinsights.com/checkout/2726

Barricade Tapes Market Landscape

Some of the key players dominating the global barricade tapes market are 3M Company, Shurtape Technologies, LLC, Brady Corporation, Scapa Group PLC, Tesa SE, Surface Shields, Inc., Advance Tapes International Ltd., Vibac Group S.p.a., Mutual Industries, Inc., Custom Tape Ltd, Intertape Polymer Group Inc., Yuyao Laisifu Houseware Co., LTD, Nitto Denko Corporation, Ningbo Teagol Adhesive Industry Co., LTD and MAS Corporation.

Microbial Therapeutic Products Market is likely to gain traction over the forecast period 2020-2030

Future Market Insights’ (FMI) global microbial therapeutic products report provides an exhaustive yet unbiased analysis of future growth projections, taking into account the aforementioned developments to provide a bird’s eye view of the landscape. According to the study, demand for microbial therapeutic products is likely to grow at a steady clip, driven chiefly by growing incidence of antimicrobial resistance.

Over the years, the burden of antimicrobial resistance (AMR) has been escalating tremendously, besides prevalence of chronic conditions. The World Health Organization observes high resistance rates have been observed against antimicrobials used for treating urinary tract infections and certain types of diarrhea. For example, the rate of resistance to ciprofloxacin ranged anywhere between 8.4% and 93% across 33 countries. It is apprehended that this burden is compounding further due to the COVID-19 pandemic. Hence, efforts are underway to accelerate research for discovering breakthroughs in microbial therapeutics.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12891

Key Takeaways

By product, anti-cancer agents to capture nearly 30% revenue by 2020-end, owing to prolific research breakthroughs
By route of administration, injection pens to account for 2 out of 5 sales, attributed to patient hygiene concerns
By source, bacteria based microbial therapeutic products to remain preferred
Oncology to remain primary microbial therapeutic products application area, expanding at Y-o-Y rate exceeding 5% through 2020
Hospitals emerge as the primary microbial therapeutic end-users, attributed to availability of adequate infrastructure
North America to remain the market hegemon, East Asia to be fastest growing market

COVID-19 Impact Analysis

The COVID-19 pandemic has adversely impact global economic outlook, with a prolonged recession on the cards across numerous industries. However, the microbial therapeutic products market has only stood to benefit from the pandemic crisis, as the global healthcare community accelerates efforts to find a potential cure for this deadly virus.

With inoculation procedures already being initiated across the U.K., it is only a matter of time before the anti-COVID-19 vaccine is available on a global scale. Despite this availability, healthcare providers will have a long road ahead with respect to discovering an orally administered drug formulation.

Therefore, governments are lending unconditional support to the global healthcare fraternity in terms of policy relaxation and disbursement of financial grants to aid in the research and development process, catapulting growth prospects.

Competitive Landscape

Prominent players operating in the global microbial therapeutic products market are emphasizing on acquiring regulatory approvals, forging partnerships and collaborations with competent authorities and biosimilars develop to capture substantial revenue shares across key regions.

Some reputed players operating within the global microbial therapeutic products landscape include Dr. Reddy’s Laboratories, Pfizer Inc., Sanofi SA, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Abbott Laboratories and Amgen Inc. to name a few.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12891

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights,
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Centrifugal Blood Pump Market sales are set to grow steadily through 2030

Future Market Insights (FMI) in a new study has projected that growth outlook for the centrifugal blood pumps market will remain strong. The market will exhibit 4% Y-o-Y growth in 2021 driven by rising cases of heart ailments recorded worldwide. A centrifugal ECMO pump is compact and delivers adequate volume of blood with relatively high pressure in order to compensate for the large pressure drop in the membrane oxygenator.

Centrifugal pumps show improved blood handling capacity and are energy-efficient. In addition to this, centrifugal pumps are small in size and represent less capital investment and have low maintenance costs. The growing preference for centrifugal blood pumps over roller pumps from hospitals and ambulatory surgical centers due to their various advantages will enable growth in the market in the coming years.

Due to the COVID-19 outbreak health care systems are negatively impacted and delivery of medical facilities effectively to all patients has become a huge challenge worldwide. Medical device manufacturers have not escaped the pandemic’s impact. Similar to pharmaceutical companies, medical device manufacturers rely heavily on healthcare facilities for their clinical trial data collection. The COVID-19 in the first few months of 2020 has imparted a negative impact on the centrifugal blood pumps market. The massive global lockdown, along with the shutting down of the economies such as China has halted the demand and supply activities. Despite this, hospitals are likely to remain leading end users owing to the advanced infrastructure and expenditure and the presence well trained medical staff and advanced facilities.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6451

Key Takeaways from Centrifugal Blood Pumps Market Study

Growth forecast for centrifugal blood pumps market remains strong as it is projected to exhibit 4% CAGR between 2020 and 2030
U.S. to spearhead growth in North America, accounting over 90% of centrifugal blood pumps sold
U.K. will showcase marginal yet steady growth 2.4% CAGR
Germany and France will continue exhibiting steady rise in demand
JAPAN and Korea to remain strong markets for centrifugal pumps in East Asia

Innovations to Remain Key to Growth

The rising demand for improved cardiac surgery will fuel the demand for centrifugal blood pumps. These pumps have low priming volume and limited contract surfaces, which make their applications ideal for certain conditions. Besides this, companies are increasingly focusing on technological innovations, which has led to the advent of lightweight centrifugal seamless blood pump with unique spherical thrust bearing.

These pumps also show the least blood trauma during cardiac surgery in comparison to other pumps available in the market, including roller pump. Advances in various cardiac assist devices aimed at curbing the incidence of adverse healthcare occurrences will continue creating growth prospects for the market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6451

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Skin Perfusion Pressure Testing Devices Market to grow at a Robust CAGR of 4.5% through 2020-2030

Skin perfusion pressure (SPP) assess the local pressure in the microcirculatory system. It is widely used parameter in assessment of wound healing potential in patients with limb ischemia and peripheral artery diseases. SPP testing devices have become crucial for wound healing in patients with chronic limb ischemia. Future Market Insights (FMI), in a new study has forecast the market for skin perfusion pressure testing devices to exhibit 4.6% Y-o-Y growth in 2021. Driven by rising healthcare spending, the market will continue exhibiting high demand through the forecast period, from 2020 to 2030.

Compared to other non-invasive methods such as toe blood pressure and ankle-brachial index, SPP provides more accurate results, and thus, its usage is gaining popularity among physicians. It has been observed that SPP can evaluate ischemic condition of the lower extremities which cannot be assessed by ankle-brachial index. This increases the preference of SPP over ABI, which in turn is expected to drive the skin perfusion pressure testing devices market.

The rising prevalence of peripheral arterial disease is another major factor driving the demand growth. Peripheral arterial disease (PAD) prevents wound healing of lower extremity. The patient populations at highest-risk have ischemic disease, foot ulcers, diabetes mellitus, and/or compromised kidney function. The most widely used test is ankle brachial index (ABI), but it has limited utility in foot ulcer patients. Ankle brachial index alone is not considered effective of wound healing. For overcoming this problem, manufacturers are focusing to develop advanced skin perfusion pressure.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9263

The COVID-19 pandemic has significantly affected the medical practices, resulting in a decrease in non-essential medical care, including the wound healing specialty. The nationwide lockdown and disrupted supply chain has limited the ability to practice wound healing in normal conditions. The pandemic in the first few months of 2020 has had a negative impact on the skin perfusion pressure testing devices market.

Manufacturers are currently focusing on designing new innovative laser dopplers that can provide better results at less cost, and at the same time give simple and reliable outputs. For instance, free flap monitoring, a new generation device provides web-based capability, whereby, recordings from a laser doppler can be transmitted directly to a smart phone. Such advancements are expected to bode well for the global market.

Key Takeaways from Skin Perfusion Pressure Testing Devices Marker Study

The global skin perfusion pressure testing devices market is estimated to be US$ 28.83 Mn in 2020, is expected to grow at a market CAGR of 4.5% during the forecast period (2020-2030)
The U.S. holds over 90% share of the North America market, but Canada is projected to expand faster at around 5.0% CAGR
Germany holds the largest share of the market in Europe, and will expand at a CAGR of around 4.8% through 2030
The U.K. will exhibit 5.3% Y-o-Y growth in 2021, emerging as a key market for SPP testing devices in Europe. France will also continue exhibiting high demand
Japan and South Korea are expected to emerge as key markets for SPP testing devices in East Asia

Who is Winning?

Leading players in the skin perfusion pressure testing devices market are strengthening their market position though the acquisition, partnerships and expansion. For Instance,

In October, 2015, Vasamed Incorporated entered into a collaboration and distribution agreement with CorVascular Diagnostics, LLC, which designs and distributes peripheral vascular diagnostic solutions.
In January 2019, Perimed AB announced a partnership with Radiometer Medical ApS (Radiometer) to accelerate and expand the distribution of Perimed PeriFlux 6000 tcpO2 standalone system.

Some of the key market players covered by FMI include Vasamed Incorporated, Moor Instruments, Perimed AB, ELCAT GmbH, ATYS Medical, Viasonix, and Promed Group, consolidating their positions through mergers, acquisitions and new product launches.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-9263

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Anti-Osteoporosis Therapy and Fracture Healing Market to progress at an impressive 5% CAGR through 2020-2030

Osteoporosis is a condition in which an individual starts losing his or her bone mass density. The condition increases the risk of bone cracks and fractures. There are several therapeutic options including oral drugs and injectable available for the treatment of osteoporosis. According to Future Market Insights (FMI), the anti-osteoporosis therapy and fracture healing market will register continued growth between 2020 and 2030. By the end of 2021, it is expected to surpass US$ 12 Bn.

Various leading market players are focusing on collaborative product development that has led to product innovation and availability of therapeutic options. For instance, GSK Consumer Healthcare has been established under single business following the completion of the merger of the consumer arms of GSK and Pfizer on August 1 in 2020

Rapidly growing ageing populations and rising prevalence of obesity expected to create considerable growth opportunities. The anti-osteoporosis therapy and fracture healing market is expected to grow significantly in terms of revenue over the forecast period owing to the increase in the availability of technologically advanced products options all over the world.

Moreover, stringent regulations are key restraints affecting growth of anti-osteoporosis therapy and fracture healing market. Side effects caused by osteoporosis drugs such as mild to fatal nausea, skin rashes, and others could affect growth of the market. Stringent regulations imposed by international organizations such as the U.S. Food and Drug Administration, which also conducts frequent revisions of side effects for osteoporosis drugs are challenging anti-osteoporosis therapy and fracture healing market growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1008

Key Takeaways from Anti-osteoporosis Therapy and Fracture Healing Market Study

Anti-osteoporosis therapy and fracture healing market is expected to register 4.5% Y-o-Y growth in 2021
The demand from the U.S. is expected to be considerably, enabling it to account for a little below 90% of the North America market
The U.K. market is expected to register 5.4% Y-o-Y growth in 2021
France and Germany are likely to exhibit considerably high demand for anti-osteoporosis therapy and fracture healing
Within East Asia, both Japan and South Korea will emerge as key markets

Product Launches Remain Key Strategy

Product approvals by the U. S. FDA for anti-osteoporosis therapy and fracture healing drugs as well as injectable are expected to push towards high competition among market players. Numerous companies are focusing on advanced product development that is convenient to use and provide rapid efficacy in the treatment of osteoporosis.

For Instance, in April 2019, Amgen Inc. announced about approval of its EVENITY® by U.S. Food and Drug Administration (FDA) used in the treatment of postmenopausal women at high risk for fracture. According to FMI, oral drugs will continue accounting for the leading market share. Oral will remain highly preferred as route of drug administration, accounting for over 64% of the market in 2021.

Who is winning?

The global market is set to broaden its scope in the forecast period, stimulated by high prevalence rate of osteoporosis, rising geriatric population globally and adoption of advanced anti-osteoporosis therapy and fracture healing products which can be used for long term care needs. In addition to this, changing regulatory dynamics and patent expiry of blockbuster drugs has constrained the sales of anti-osteoporosis therapy and fracture healing products.

The key market players covered by FMI include Eli Lilly and Company, Pfizer, Inc., Amgen Inc., Merck and Company Inc., Novartis International AG, F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd. and GlaxoSmithKline Plc. consolidating their positions through mergers, acquisitions and new product launches.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1008

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Realtime Bioprocess Raman Analyzer Market is expected to grow at a CAGR of 18.9% during the forecast period 2020-2030

The benefits of Raman spectroscopy as data processing in real-time has made significant contribution as a diagnostic and control tool for pharmaceutical production and bioprocessing, with scientific and financial benefits demonstrated throughout the product life cycle. This has led to the growth of real-time bioprocess Raman analyzers market. Future Market Insights (FMI) in a new study has forecast real-time bioprocess raman analyzers market to expected to exhibit a CAGR of 14.6% during the forecast period (2020-2030).

Leading market players are focusing on mergers and acquisitions with biopharmaceutical industries and contract manufacturing organizations (CMO). This would help them expand their global footprint. Among end-use segments, contract manufacturing organizations are leading the market, which is then followed by biopharmaceutical companies. Contract manufacturing organizations are anticipated to grow at a CAGR of around 15.9% over the forecast period.

Increasing biopharmaceutical production and reduced cost benefits are expected to fuel Real-time bioprocess Raman Analyzers market growth in the coming decade. The digital transformation for data processing in real-time rising investments into R&D and initiative by regulatory bodies to improvise the development and approval process of biopharmaceutical products and fast track the process is has led to the real-time bioprocess Raman Analyzers market growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6912

However, there are few challenges in the real-time bioprocess raman analyzers market like the availability of a skilled workforce which is acting as a restraint in the growth of the market. Lack of information about the product leading to lesser adoption of the Real-time bioprocess Raman Analyzers is acting as a restraint for the market growth.

Key Takeaways from Real-time bioprocess Raman Analyzers Market Study

The global Real-time bioprocess Raman Analyzers market is estimated to surpass US$ 8.7 Mn by 2021
The U,S, will emerge as dominant market in North America, accounting for over 95% of the overall sales
The U.K. will exhibit growth at a positive pace. According to FMI, it is expected to register nearly 20% Y-o-Y growth in 2021
Both Germany and France are expected to emerge as attractive markets for realtime bioprocess raman analyzer in Europe
Within East Asia, China will account for higher share of proceeds gained by the market

Who is Winning?

The global market is set to broaden its scope in the forecast period, driven by the increasing adoption rate of real-time and automated solutions during bioprocessing, advancements in technology, and reduced cost in manufacturing of biopharmaceuticals. However, lack of a skilled workforce and inadequate information about the benefits has constrained the sales of Real-time bioprocess Raman Analyzers.

Some of the key players operating in the market are Kaiser Optical Systems (Endress+Hauser), Resolution Spectra Systems Inc. (Merck KGaA), Tornado Spectral Systems, and Sartorius AG. Leading companies are consolidating their positions through mergers, acquisitions, and collaborations.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-6912

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Wound Debridement Products Market will grow at a Robust CAGR during the forecast period of 2021 to 2031

Demand for wound debridement products is surging steadily owing to its steady demand, especially from hospitals and specialty clinics. The new edition of the report from Future Market Insights (2021-2031) offers a post COVID-19 analysis on wound debridement sales across the globe. The report also expands on the previous competitive section, with divestures, mergers & acquisitions, and new forays analyzed.

According to latest analysis, wound debridement product sales have witnessed a minor decline in US, the largest market globally. However, demand still continues to be strong and manufacturers can expect a steady stream of opportunities during the forecast period. US currently accounts for nearly one-fourth of all wound debridement sales globally.

The study also finds that manufacturers are focusing on launching innovative products to consolidate their market share.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-584

Key Takeaways from Study

Hospitals will remain the largest demand generators for wound debridement products
Strong demand in US to continue in 2021 and beyond, making North America the largest market globally
New product innovation to be a key focus area for manufacturers
Demand for wound debridement products rising in Asia Pacific as various economies make an early recovery from COVID-19 pandemic

Applications in Treating Chronic Ulcers and Surgical Wounds Driving Demand

Demand for wound debridement products continues to remain high for treating chronic ulcers and surgical wounds. According to the study, these two application areas continue to create opportunities for market players. Of particular significant is application in chronic leg ulcers. Chronic ulceration of lower legs continues to be a challenge area, with 3.6% of people older than 65 years suffering from this (Grant Medical College).

FMI’s study reveals that use of wound debridement products in treating these types of ulcers will continue to account for steady demand over the course of the forecast period.

Demand Likely to Increase in Asia Pacific

FMI’s analysis reveals US to be the most lucrative market for wound debridement products, but owing to relatively less impact on many Asian economies, demand is likely to surge.

China, India, and South East Asian countries have been lesser impacted by the covid-19 crisis, as compared to US and Western Europe. Further, healthcare sector in these countries is going through an infrastructure revamp, which is also likely to create opportunities for manufacturers.

Who is Winning in this Space?

The global wound debridement products market is extremely competitive in nature. According to FMI, majority of the players in the wound debridement products market are focusing on acquisitions and launching new and effective product variants

For instance, Axio Biosolutions, a leading Indian company working in the industry, is consistently working on the creation of an emergency wound hemostat. The company also launched an effective dressing namely “Axiostat” which gained a whole lot of importance and wide acceptance across the defense forces and civil hospitals. The dressing has helped majorly in preventing bleeding in the wounds.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-584

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Pulmonology Devices Market is projected to expand at a CAGR close to 10.7% through 2020-2030

Respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), and lung cancer is on the rise globally. Smoking and unhealthy living environment are often identified as common causes fuelling the incidence of respiratory disorders. According to Future Market Insights (FMI), driven by the rising incidence of respiratory diseases the demand for pulmonology devices will rise. The market is therefore expected to surpass US$ 1.08 Bn by 2021.

Government initiatives supported by public and private organizations to spread awareness has led people to focus on early diagnosis of medical conditions to avoid delay in treatment. Furthermore, a number of players are developing new products to expand their product portfolio as well as to maintain their position in the market.

For an instance Olympus has launched a few unique pulmonology devices such as the flexible bronchoscope that has helped the company in maintaining its position in the market. A large number of domestic players are slowly emerging in Asia Pacific. Rise in healthcare expenditure in developing countries and improving reimbursement policies are causing shift in focus among market players from developed to developing countries.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13036

Moreover, the availability of pulmonology devices for healthcare professionals has been impacted by COVID-19 supply chain crisis. However, there are measures taken to manage this situation. Governments have relaxed controls to make supply easy. Export controls have been made easy by several manufacturing countries.

Major manufacturers in the pulmonology devices market are geared up and focusing on local production of pulmonology devices. According to the report, the increasing cases COPD and lung cancer will continue fuelling demand in the market.

Key Takeaways from pulmonology devices Marker Study

The demand for pulmonology devices is expected to get higher, enabling the market to exhibit 10.8% CAGR between 2020 and 2030
Backed by increasing healthcare spending, the U.S. is expected to account for nearly 90% sales in North America
Favorable reimbursement policies will enable the U.K. to exhibit 13% y-o-y growth in 2021
Germany and France will showcase increasing investment towards expanding healthcare infrastructure, in turn fuelling the demand for pulmonology devices
Within East Asia, Japan and South Korea will represent highly attractive markets for sale

Who is Winning?

Leading players in the pulmonology devices market on strengthening their market position though the Acquisition, Partnerships and expansion.

The key market players covered by FMI include Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Cook Medical Incorporated, Medi-Globe GmbH, Ambu A/S, Verathon, Inc, consolidating their positions through mergers, acquisitions and new product launches.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13036

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Medication Management System Market is predicted to expand at over 15% CAGR through 2021-2031

The global medication management system industry is gaining momentum as lack of enough pharmacist and healthcare professionals is necessitating the requirement for efficient management system to ensure the workflow. While the pandemic has brought substantial changes in medical and healthcare industry due to shifted demand-supply patterns, the need to curtail medical errors grew stronger resulting in prominent demand for medication management systems.

The latest revised edition of the report on ‘medication management system’ market study by Future Market Insights (FMI) offers a detailed insights of the global industry, growth & restraining factors, and demand-supply trajectories across 20+ countries during the forecast period of 2021 to 2031. According to the report, the industry players will thrive on the rising number of machines and inventory management equipment in the hospitals and healthcare sectors while eyeing the main regions such as North America, Europe, and Asia Pacific, to name a few.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1419

Key Takeaways from Market Study

The global medication management system industry to ascend at over 15% CAGR through 2031
High requirement for computerized physician order entry and inventory management solutions is likely to be witnessed
Growing requirement from hospitals and pharmacies to favor manufacturers
On-premise and web-based solutions to gain traction in terms of mode of delivery
The United States to remain the epicenter of the world’s largest medication management system industry North America
Germany to remain dominant in the Europe medication management system industry
Asia-Pacific to exhibit the fastest growth during the forecast period
China, Japan, India, the United Kingdom, France, Italy, and a few other countries to remain lucrative for stakeholders

How is the Increase in Demand from Hospitals Industry Fuelling Sales of Medication Management System Suppliers?

Medication management systems are being deployed extensively by healthcare professionals in order to efficiently manage various information such as patient analysis, regulatory & compliance information, valuation analysis and other vital parameters in healthcare industry.

According to the report titled “Industries at a Glance: Hospitals” published by the Bureau of Labor Statistics, the United States hospitals industry is highly potential and progressive and comprises of medical, diagnostic, treatment, and other inpatient and outpatient services which include physician, nursing, and other health services. As stated in the report, the employment in this sector has decreased to 5,135.1 in thousands in February, 2021, compared to 5,136.3 in thousands in November, 2020. These data give a glimpse of the upcoming opportunities for medication management system providers around the globe.

Who is Winning in this Space?

With the competition getting stricter, key players in the global medication management system market are diversifying their products in order to target broader end-use sectors.

For instance,

Omnicell, Inc. lunched its new extensive range of products such as i.v.STATION Non-hazardous Compounding Robot, IVX Workflow, AccuFlex, MTS-350 Filler and Sealer, and others during the last 5 years
Cerner Corporation launched its new Automated Dispensing Cabinet, Drug Database Solutions, and others a couple of years back

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1419

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us: